Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 14:10:257-271.
doi: 10.2147/MDER.S144048. eCollection 2017.

Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study

Sabine Ettinger  1 , Michal Stanak  1 , Piotr Szymański  2 , Claudia Wild  1 , Romana Tandara Haček  3 , Darija Erčević  3 , Renata Grenković  3 , Mirjana Huić  3
Affiliations

Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study

Sabine Ettinger et al. Med Devices (Auckl). .

Abstract

Aim: To summarize the evidence on clinical effectiveness and safety of wearable cardioverter defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest in patients at risk.

Methods: We performed a systematic literature search in databases including MEDLINE via OVID, Embase, the Cochrane Library, and CRD (DARE, NHS-EED, HTA). The evidence obtained was summarized according to GRADE methodology. A health technology assessment (HTA) was conducted using the HTA Core Model® for rapid relative effectiveness assessment. Primary outcomes for the clinical effectiveness domain were all-cause and disease-specific mortality. Outcomes for the safety domain were adverse events (AEs) and serious adverse events (SAEs). A focus group with cardiac disease patients was conducted to evaluate ethical, organizational, patient, social, and legal aspects of the WCD use.

Results: No randomized- or non-randomized controlled trials were identified. Non-comparative studies (n=5) reported AEs including skin rash/itching (6%), false alarms (14%), and palpitations/light-headedness/fainting (9%) and discontinuation due to comfort/lifestyle issues (16-22%), and SAEs including inappropriate shocks (0-2%), unsuccessful shocks (0-0.7%), and death (0-0.3%). The focus group results reported that experiencing a sense of security is crucial to patients and that the WCD is not considered an option for weeks or even months due to expected restrictions in living a "normal" life.

Conclusion: The WCD appears to be relatively safe for short-to-medium term, but the quality of existing evidence is very low. AEs and SAEs need to be more appropriately reported in order to further evaluate the safety of the device. High-quality comparative evidence and well-described disease groups are required to assess the effectiveness of the WCD and to determine which patient groups may benefit most from the intervention.

Keywords: cardioverter defibrillator; external; patient involvement; sudden cardiac arrest; ventricular fibrillation; ventricular tachycardia; wearable.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flow chart of the selection process according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Note: Data from Ettinger et al.
See this image and copyright information in PMC

References

    1. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) Eur Heart J. 2015;36(41):2793–2867. - PubMed
    1. APA-OTS Ärztekammer: Höhere Überlebensraten bei Herzstillstand sind machbar [Austrian Medical Chamber: higher survival rates in cardiac arrest patients are feasible] 2013. [Accessed September 29, 2016]. Available from: http://www.ots.at/presseaussendung/OTS_20131015_OTS0124/aerztekammer-hoe.... German.
    1. Mozaffarian D, Benjamin EJ, Go AS, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–e322. - PubMed
    1. Myerburg RJ, Juntilla MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125(8):1043–1052. - PubMed
    1. Haute Autorité de Santé . LifeVest 4000. St Denis: Haute Autorité de Santé; 2014.